Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Allergan

Allergan
1983 FOUNDED
PUBLIC STATUS
1K-5K EMPLOYEES
AGN STOCK SYMBOL
52 INVESTMENTS
$188.34 SHARE PRICE (As of Friday Closing)
Description

Allergan is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. In 2016, Allergan sold its generics and distribution segments to Teva.

Formerly Known As
Watson Pharmaceuticals, Actavis
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Stock Exchange
NYS
Primary Office
  • Clonshaugh Business and Technology Park
  • Coolock
  • Dublin D17 E400
  • Ireland

+353 (021) 000 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Allergan’s full profile, request a free trial.

Allergan Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$114.27 - $190.41 $61.8B $188.27 -$27.87 2.25M 328M

Allergan Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 76,504,644 67,468,240 84,242,043 89,055,611
Revenue 15,817,600 15,787,400 15,940,700 14,570,600
EBITDA (3,445,700) 757,700 (1,989,900) 5,024,700
Net Income (9,253,700) (5,096,400) (4,125,500) 14,973,400
Total Assets 94,408,900 101,787,600 118,341,900 128,986,300
Total Debt 23,081,000 23,797,700 30,075,300 32,768,700
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Allergan Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Allergan‘s full profile, request access.

Request full access to PitchBook

Allergan Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mylan Corporation Hatfield, United Kingdom 00000 00.00 000000&0 00.00
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
000000 000000 0000 Corporate Backed or Acquired Laval, Canada 00000 000.00 00000000000 000.00
0000000 & 0000000 Corporation New Brunswick, NJ 000000 0000
0000000 0000000 Corporation Dublin, Ireland 00000 000000&0
To view this company’s complete list of competitors, request access »

Allergan Investments & Acquisitions (52)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 27-Jun-2019 000000000 Drug Discovery
0000 0000000 26-Mar-2019 000000000000000000 000.00 Personal Products 000000 00000
00000 24-Oct-2018 000000000000000000 00000 Drug Discovery 0000000 00000000 00
000000000 06-Apr-2018 000000000000000000 00000 Biotechnology 0000000 00000
Repros Therapeutics 31-Jan-2018 Merger/Acquisition 000.00 Drug Discovery 00000 000000000 00.0
To view this company’s complete investment and acquisition history, request access »

Allergan Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 00000000 31-Oct-2012 000000000000000000 00.000 Completed
  • 00000000
0000000 14-Oct-2010 00000 00000 00 0000 Completed
  • 5 buyers
Anda Merger/Acquisition Completed
To view this company’s complete exits history, request access »

Allergan Subsidiaries (16)

Company Name Industry Location Founded
Akarna Therapeutics Drug Discovery Encinitas, CA 2014
000000000000 Hospitals/Inpatient Services San Francisco, CA 0000
0000000000 0000000 Biotechnology Ann Arbor, MI 0000
000000 00000000000 Pharmaceuticals Chicago, IL 0000
000000 0000000 Surgical Devices Stuart, FL 0000
To view this company’s complete subsidiary history, request access »

Allergan Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Allergan‘s full profile, request access.

Request full access to PitchBook

Allergan Executive Team (56)

Name Title Board
Seat
Contact
Info
Brenton Saunders JD Chief Executive Officer & Chairman
Matthew Walsh Chief Financial Officer & Executive Vice President
James D'Arecca Chief Accounting Officer
Robert Bailey JD Corporate Secretary, Chief Legal Officer & Executive Vice President
David Moss Director Corporate Business Development

27 Former Executives

You’re viewing 5 of 56 executives. Get the full list »

Allergan Board Members (7)

Name Representing Role Since Contact
Info
0000000 00000000 00 Allergan Chief Executive Officer & Chairman 000 0000
00000 00000000 Allergan Board Member 000 0000
00000 000000 Allergan Board Member 000 0000
000000 00000 Self Board Member 000 0000
000000 0000000 Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 7 board members. Get the full list »